MDMA as the future of PTSD treatment
For decades, trauma survivors have been told that time heals, that talking about their pain in therapy can be a tool to let go of their pain, or that using medications can dull the symptoms and effects of their suffering. For many living with PTSD, the reality is far more complicated. Traditional treatments like antidepressants, cognitive behavioral therapy, and exposure therapy to their trauma may help some people, but others may continue to struggle with flashbacks, nightmares, anxiety, and disconnection from life. Studies have shown that MDMA, more commonly known as ecstasy or molly, is becoming more useful as a treatment for PTSD. While usually used as a party drug, MDMA is now at the center of multiple scientific studies regarding its effects on PTSD, and the results are eye-opening.
MDMA affects the brain in ways that make trauma therapy more effective, increasing serotonin, dopamine, and oxytocin, which are the chemicals linked to mood, bonding, and feelings of trust. In a therapeutic setting, MDMA can be used to make patients feel safer and more connected to their therapist, and less overwhelmed with the process of revisiting traumatic memories. Unlike traditional talk therapy, which may retraumatize some patients, MDMA-assisted therapy sessions can allow some survivors to re-engage with painful and traumatic memories without feeling fear or shame. This emotional buffer that MDMA gives patients allows them to process their experiences with clarity rather than avoidance.
According to the VA’s National Center for PTSD, MDMA-assisted therapy happens in carefully controlled settings, only one to three settings each lasting six to eight hours, and spaced several weeks apart. Patients will lie down and listen to music while being watched by two therapists.
Research regarding MDMA as a successful treatment for PTSD is showing that while using MDMA as a tool for PTSD and trauma treatment, symptoms dropped significantly, with around two-thirds of recipients of MDMA no longer meeting the criteria for PTSD. It has been found that MDMA can also work with depression, disassociation, substance use and abuse histories, and childhood trauma. This type of therapy, while using a typical “party drug,” was deemed safe and well tolerated by patients, with no increase in suicidal thoughts or health-related issues.
It is fascinating to think that a generally known “club” drug can be used to help folks with PTSD and trauma, and help them move past these experiences. While MDMA is still considered a Schedule 1 drug, meaning it is illegal for general medical use, its use is allowed in approved medical clinical trials. When used in a clinical setting with a trained therapist over multiple sessions, MDMA may offer a safe yet powerful route to healing that many PTSD sufferers have not had access to or attempted yet.
References:
MDMA-Assisted Therapy for PTSD. Va.gov: Veterans Affairs. (2025, January 15). https://www.ptsd.va.gov/understand_tx/mdma_assisted_therapy.asp
Riaz, K., Suneel, S., Hamza Bin Abdul Malik, M., Kashif, T., Ullah, I., Waris, A., Di Nicola, M., Mazza, M., Sani, G., Martinotti, G., & De Berardis, D. (2023). MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence. Diseases (Basel, Switzerland), 11(4), 159. https://doi.org/10.3390/diseases11040159